Study Recommends Reduction In Dose For Breast PEM With Preservation Of Image Quality

In a new study presented at the American Association of Physicists in Medicine (AAPM) 52nd Annual Meeting, researchers at the University of Washington reported that 18FDG dose for Positron Emission Mammography (PEM) could be reduced by as much as 70% without affecting image quality. PEM scanners are high-resolution breast PET systems that show the site as well as the metabolic phase of a lesion. The metabolic view enables doctors to take the optimal decision for patient care by providing an unequalled ability to discriminate between benign and malignant lesions, what is called "specificity".